render accurate pre-operative staging paramount. Incidental indeterminate pulmonary nodules (IPNs) are a common pre-operative finding in clinical practice, thus representing a significant management challenge since metastatic patients are unlikely to benefit from extirpation. Thus, we sought to evaluate the natural history of IPNs in a large institutional cohort that underwent RC.
INTRODUCTION AND OBJECTIVES: Urothelial carcinoma of the bladder presents often morphological features that differ from the urothelial common aspect. Specifically, this parameter may change the therapeutic approach at the time of transurethral resection (TUR). However, data are scarce regarding the concordance of histological variants at TUR using radical cystectomy (RC) features as a reference. The aim of our study was to report incidence of histological variants in TUR and RC and to evaluate the agreement between TUR and RC considering histological variants.
METHODS: A total of 779 patients treated with TUR and subsequently with RC and pelvic lymph node dissection between 1990 and 2013 at a single tertiary referral center were included in the study. Patients treated with neoadjuvant chemotherapy were excluded from the study due to the aim of work. Dedicated uropathologists evaluated TUR and RC at the same tertiary referral center. Variant histology classification used in our analyses were: sarcomatoid, small cell, squamous or micropapillary. All the other variants were group together as found in less than 10 patients. Grade agreement was calculated using the Cohen kappa coefficient. Absolute value ranges between 0 and 1, where 0 represents pure chance agreement, and 0.1 to 0.4, 0.4 to 0.75, and 0.75 to 1.0, respectively, represent poor, intermediate, and good agreement. Univariable and multivariable logistic regression evaluated the association between the presence of histological variants at TUR and the risk of incur in adverse pathologic features at RC.
RESULTS: Considering TUR, 213 (27.3%) patients were diagnosed with histological variants. Of these, 2.1% (n¼16) were found with sarcomatoid variant, 1.7% (n¼13) with small cell, 7.1% (n¼55) with squamous, 12.5% (n¼97) with micropapillary and 4.1% (n¼32) defined as others. Considering RC, 212 (27.2%) patients were diagnosed with histological variants. Of these, 2.1% (n¼16) were found with sarcomatoid variant, 1.7% (n¼13) with small cell, 3.9% (n¼30) with squamous, 10.2% (n¼78) with micropapillary. Cohen kappa concordance was used to analyze agreement between TUR and RC considering histological variants. In general, poor agreement was found considering micropapillary variant and the presence of an histological variant in general (0.11 and 0.27, respectively). On the other hand, intermediate agreement was found analyzing the presence of sarcomatoid, small cell and squamous variants (0.43, 0.61 and 0.61, respectively). At multivariable analyses, none of the histological variants evaluated at TUR were found to be associated to adverse pathologic stage or node positive disease at RC (all p>0.06). Conversely diagnosis of small cell carcinoma at TUR was found associated with an increased risk of harboring positive STSM (Odds ratio:2.08, confidence interval:1.27-3.41, p¼0.03).
CONCLUSIONS: The presence of histological variants is a common finding in BCa patients. However, considering this aspect we found poor concordance between TUR and RC. Our findings highlight the necessity of developing new biomarkers to increase the diagnostic value of TUR which may change the therapeutic indication for RC or the necessity of neoadjuvant treatment.
Source of Funding: none

MP58-14 LIMITS OF TRANSURETHRAL RESECTION IN DETECTING UNCOMMON HISTOLOGICAL VARIANTS WITHIN BULKY BLADDER TUMORS IN REAL-LIFE CLINICAL PRACTICE
Cristina Scalici Gesolfo*, Alessio Guarneri, Sandro Billone, Palermo, Italy; Marco Moschini, Renzo Colombo, Matteo Ferro, Ottavio De Cobelli, Milan, Italy; Alchiede Simonato, Vincenzo Serretta, Palermo, Italy INTRODUCTION AND OBJECTIVES: Rare histotypes represent almost 10% of bladder tumors, more often represented within large and muscle invasive transitional cell carcinomas of the bladder (MIBC). Neoadjuvant chemotherapy is recommended (Grade A) by international guidelines. Rare histological variants, more aggressive and less responsive to systemic chemotherapy might remain unrecognized at initial transurethral resection (TURBT) in everyday clinical practice. We investigated the accuracy of TURBT in detecting rare histological variants in patients with large bladder tumors candidate to cystectomy.
METHODS: The clinical and pathologic data of 540 patients submitted to TURBT and/or cystectomy for bladder cancer between Jan. 2010 and Oct. 2016, were reviewed. The presence of uncommon histotypes within urothelial bladder carcinoma has been assessed. Rare variants were diagnose according WHO criteria. Standard hematoxilyn-eosin stain was adopted and further immunohistochemistry was performed. Inferential statistical analysis was performed. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e777 RESULTS: Out of 540 patients, 43 (7,9%) showed rare histotypes of bladder cancer. In 5 (11,6%) cases the uncommon histotypes was revealed by palliative TURBT . The remaining 38 patients were submitted to cystectomy for bladder tumors of considerable size (mean diameter 7,8 cm; range of 5-11 cm); 14 (36,8%) harbored a pT4 tumor. The rare histotypes were: squamous carcinoma 6 (13,9%), sarcomatoid 2 (4,8%), undifferentiated 5 (11,6%), neuroendocrine 3 (6,9%), mixed 27 (62,8%). TUR revealed an uncommon histotypes in 26 (68,4%) cases only. Moreover, in 5 (23.8%) patients an additional uncommon histology not detected by previous TUR, was demonstrated in cystectomy specimens.
CONCLUSIONS: The prognostic role of uncommon histotypes in bladder cancer is well documented. Unrecognized rare histotypes might have important therapeutic implications since possibly less responsive to neoadjuvant chemotherapy. These patients could benefit from an immediate cystectomy avoiding neo-adjuvant chemotherapy. The inaccuracy of TUR in everyday clinical practice in detecting uncommon variants could be explained by an inadequate sampling of large tumors. The 00 pre-cystectomy 00 TUR is often performed only to confirm the infiltration. As a matter of fact, the pathologists might not receive an adequate amount of tissue. To standardize the TURBT strategy including sampling of different areas of bulky tumors could be of clinical value in patients undergoing neoadjuvant chemotherapy.
Source of Funding: none
MP58-15 IMPACT OF TUMOR HISTOPATHOLOGIC TYPES ON PATTERN OF TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC).
Ahmed Mansour*, Mahmoud Laymon, Mohamed M. Elsaadany, Ahmed Mosbah, Shaaban AA, Hassan Abol-enein, Mansoura, Egypt INTRODUCTION AND OBJECTIVES: To compare patterns of tumor recurrence of common histological types of bladder cancer after radical cystectomy. Predictors of cancer specific survival (CSS) were also identified.
METHODS: The records of 1737 consecutive patients treated with radical cystectomy between January 2004 till February 2014 were reviewed. A total of 937, 318, 223and 70 patients were diagnosed with urothelial carcinoma (UC), SCC,UC with squamous differentiation (SqD) and adenocarcinoma (AC) respectively. Clinical tumor recurrences were classified as local, when recurred in the soft tissue of pelvis and / or pelvic lymph nodes. Distant metastasis, on those recurred in remote sites including extrapelvic lymph nodes. Cancer specific survival (CSS) was estimated using Kaplan-Meier survival method and compared with log rank test.
RESULTS: Mean patient age was 58.4AE8.1 years. Median follow up period was 23 months (IQR 9-57 months). Patients' characteristics are demonstrated in Table1. Five year CSS was 77.9%, 77.8%, 67.3% and 59.8% for SCC, AC, UC and SqD respectively (p ¼ 0.009). Patients with SqD had the highest incidence of local pelvic recurrence reaching 21% followed by SCC (15.4%). Distant metastasis was observed in 157 (16.8%) and 41(18.4%) patients with UC and SqD respectively in comparison to 7(10%) and 20 (6.3%) in adenocarcinoma and SCC cases respectively. Bone was the commonest site of distant metastasis. The independent prognostic factors of CSS, of all treated patients, on multivariate analysis were T stage (pT3-4 vs pT0-2) (HR 3, 95% CI 2.3-3.9, P < 0.0001), lymph node metastasis (HR 1.7, 95% CI 1.29-2.2, P <0.0001), lymphovascular invasion (HR 1.5, 95% CI 1.1-2, P ¼ 0.001) and obstructive uropathy at presentation (HR 2.2, 95% CI 1.4-3.4, P < 0.0001).
CONCLUSIONS: After radical cystectomy, distant tumor metastasis was more frequently observed in UC and its variant while local recurrence was more common in patients with SCC and adenocarcinoma. 
